{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:38:20Z","timestamp":1792139900408,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112081","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T18:52:48Z","timestamp":1629917568000},"page":"112081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism"],"prefix":"10.1016","volume":"142","author":[{"given":"Zhong","family":"Xian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhuo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.112081_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(94)90964-4","article-title":"Identification of aristolochic acid in Chinese herbs","volume":"343","author":"Vanhaelen","year":"1994","journal-title":"Lancet"},{"issue":"8842","key":"10.1016\/j.biopha.2021.112081_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.112081_bib4","first-page":"1","article-title":"Some traditional herbal medicines, some mycotoxins, naphthalene and styrene","volume":"82","author":"Cancer","year":"2002","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"issue":"4","key":"10.1016\/j.biopha.2021.112081_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid as a probable human cancer hazard in herbal remedies: a review","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8546-3-13","article-title":"Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003","volume":"3","author":"Hsieh","year":"2008","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00216-007-1310-3","article-title":"Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market","volume":"389","author":"Martena","year":"2007","journal-title":"Anal. Bioanal. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112081_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mrfmmm.2006.08.004","article-title":"DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver","volume":"602","author":"Mei","year":"2006","journal-title":"Mutat. Res.-Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.biopha.2021.112081_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2019.10.241","article-title":"Health risk associated with the oral consumption of \u201cChiniy-tref\u201d, a traditional medicinal preparation used in Martinique (French West Indies): qualitative and quantitative analyses of aristolochic acids contained therein","volume":"172","author":"Riffault-Valois","year":"2019","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.biopha.2021.112081_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102144","article-title":"DNA adducts formed by aristolochic acid are unique biomarkers of exposure and explain the initiation phase of upper urothelial cancer","volume":"18","author":"Stiborova","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"29","key":"10.1016\/j.biopha.2021.112081_bib11","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/gfm667","article-title":"Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy","volume":"23","author":"de Jonge","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112081_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chroma.2007.06.055","article-title":"A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines","volume":"1164","author":"Chan","year":"2007","journal-title":"J. Chromatogr. A"},{"issue":"5","key":"10.1016\/j.biopha.2021.112081_bib14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/19440049.2014.892215","article-title":"Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high-performance liquid chromatography\u2013multistage fragmentation mass spectrometry","volume":"31","author":"Vaclavik","year":"2014","journal-title":"Food Addit. Contam. Part A"},{"issue":"16","key":"10.1016\/j.biopha.2021.112081_bib15","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM200310163491619","article-title":"Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert","volume":"349","author":"Gold","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112081_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1039\/c3np70114j","article-title":"Naturally occurring aristolochic acid analogues and their toxicities","volume":"31","author":"Michl","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2021.112081_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1039\/b303648k","article-title":"Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities","volume":"20","author":"Kumar","year":"2003","journal-title":"Nat. Prod. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.111.180984","article-title":"Physiological and molecular characterization of aristolochic acid transport by the kidney","volume":"338","author":"Dickman","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00302751","article-title":"The carcinogenic action of aristolochic acid in rats","volume":"51","author":"Mengs","year":"1982","journal-title":"Arch. Toxicol."},{"issue":"412","key":"10.1016\/j.biopha.2021.112081_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan6446","article-title":"Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia","volume":"9","author":"Ng","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.biopha.2021.112081_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/iju.13376","article-title":"Epidemiology of urothelial carcinoma","volume":"24","author":"Miyazaki","year":"2017","journal-title":"Int. J. Urol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112081_bib22","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1523-1755.2005.00277.x","article-title":"Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells","volume":"67","author":"Balachandran","year":"2005","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice","volume":"56","author":"Sato","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112081_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jep.2017.11.008","article-title":"Oral chronic toxicity study of geniposide in rats","volume":"213","author":"Tian","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2021.112081_bib25","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/minf.201300103","article-title":"Comparing the chemical structure and protein content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target","volume":"32","author":"Southan","year":"2013","journal-title":"Mol. Inform."},{"issue":"W1","key":"10.1016\/j.biopha.2021.112081_bib26","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2021.112081_bib27","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2021.112081_bib28","doi-asserted-by":"crossref","first-page":"020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database"},{"key":"10.1016\/j.biopha.2021.112081_bib29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3389\/fphar.2019.01629","article-title":"Network pharmacology-based strategy to investigate the pharmacologic mechanisms of Atractylodes macrocephala Koidz. for the treatment of chronic gastritis","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"D1","key":"10.1016\/j.biopha.2021.112081_bib30","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib31","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.3390\/ijms16023579","article-title":"Analysis of dermal papilla cell interactome using STRING database to profile the ex vivo hair growth inhibition effect of a vinca alkaloid drug, colchicine","volume":"16","author":"Hsia","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib32","first-page":"1","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-018-2347-x","article-title":"Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology","volume":"18","author":"Bing","year":"2018","journal-title":"BMC Complement. Altern. Med."},{"issue":"9","key":"10.1016\/j.biopha.2021.112081_bib34","first-page":"3244","article-title":"An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets","volume":"39","author":"Sinha","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"10.1016\/j.biopha.2021.112081_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.30863","article-title":"The mutational features of aristolochic acid\u2013induced mouse and human liver cancers","volume":"71","author":"Lu","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112081_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00333900","article-title":"On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid","volume":"52","author":"Mengs","year":"1983","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112081_bib37","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00293699","article-title":"Tumour induction in mice following exposure to aristolochic acid","volume":"61","author":"Mengs","year":"1988","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2021.112081_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jep.2018.07.001","article-title":"Oral administration of Aristolochia manshuriensis Kom in rats induces tumors in multiple organs","volume":"225","author":"Wang","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"197","key":"10.1016\/j.biopha.2021.112081_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006086","article-title":"Genome-wide mutational signatures of aristolochic acid and its application as a screening tool","volume":"5","author":"Poon","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.112081_bib40","doi-asserted-by":"crossref","first-page":"e83922","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.biopha.2021.112081_bib41","first-page":"5464","article-title":"Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues","volume":"50","author":"Schmeiser","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2021.112081_bib42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fphar.2019.00648","article-title":"Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112081_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/em.22321","article-title":"Bioactivation mechanisms of N\u2010hydroxyaristolactams: nitroreduction metabolites of aristolochic acids","volume":"60","author":"Okuno","year":"2019","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib44","first-page":"41","article-title":"A systematic review of the possible carcinogenic role of the aristolochic acid","volume":"58","author":"Bara","year":"2017","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.biopha.2021.112081_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrgentox.2017.03.003","article-title":"TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: new evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis","volume":"818","author":"Aydin","year":"2017","journal-title":"Mutat. Res.\/Genet. Toxicol. Environ. Mutagen."},{"issue":"8","key":"10.1016\/j.biopha.2021.112081_bib46","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00204-021-03077-1","article-title":"Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo","volume":"95","author":"Wan","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112081_bib47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/nep.12128","article-title":"Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K\/Akt pathway in the pathogenesis of renal interstitial fibrosis","volume":"18","author":"Qin","year":"2013","journal-title":"Nephrology"},{"issue":"4","key":"10.1016\/j.biopha.2021.112081_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/aps.2014.155","article-title":"The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K\/Akt\/Smad pathway","volume":"36","author":"Yu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/cr400307e","article-title":"(\u2212)-Cytisine and derivatives: synthesis, reactivity, and applications","volume":"114","author":"Rouden","year":"2014","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00441-011-1201-y","article-title":"Non-Smad signaling pathways","volume":"347","author":"Mu","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.112081_bib51","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/cells8090960","article-title":"Transforming growth factor-beta (TGF\u03b2) signaling pathway in cholangiocarcinoma","volume":"8","author":"Papoutsoglou","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2021.112081_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112081_bib53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ki.2014.287","article-title":"Origin of myofibroblasts and cellular events triggering fibrosis","volume":"87","author":"Mack","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2021.112081_bib54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2021.112081_bib55","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160107","article-title":"Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis","volume":"36","author":"Robert","year":"2016","journal-title":"Biosci. Rep."},{"issue":"14","key":"10.1016\/j.biopha.2021.112081_bib56","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.addr.2010.08.012","article-title":"Targeting podocyte-associated diseases","volume":"62","author":"Leeuwis","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2021.112081_bib57","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022137","article-title":"Signaling cross talk between TGF-\u03b2\/Smad and other signaling pathways","volume":"9","author":"Luo","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221008647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:43:27Z","timestamp":1760100207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221008647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":57,"alternative-id":["S0753332221008647"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112081","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the potential nephrotoxicity and mutagenicity of aristolochic acid IVa and its mechanism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112081"}}